Table 3.
Comparisons between adult patients infected with T6SS-positive and T6SS-negative C. jejuni
| T6SS-positive | T6SS-negative | p-value | |
|---|---|---|---|
| (n = 20) | (n = 99) | ||
| Baseline characteristics | |||
| Age (median years) | 58 (46–77) | 57 (31–74) | n.s. |
| Male gender | 13 (65.0) | 61 (61.6) | n.s. |
| Hospitalised patients | 12 (60.0) | 61 (61.6) | n.s. |
| Duration of hospital stay (median days) | 3 (0–5) | 1 (0–5) | n.s. |
| ICU stay (yes) | 1 (5.0) | 1 (1.0) | n.s. |
| Comorbidities | |||
| Charlson Comorbidity Index | 2 (1–5) | 0 (0–1) | < 0.001 |
| Solid organ transplant | 4 (20.0) | 3 (3.0) | 0.015 |
| Immunosuppressant therapy | 6 (30.0) | 9 (9.1) | 0.019 |
| Clinical characteristics | |||
| Bacteraemia | 0 (0.0) | 6 (6.1) | n.s. |
| Fever history (yes) | 6 (30.0) | 56 (56.6) | 0.048 |
| Bloody diarrhoea (yes) | 2 (10.0) | 19 (19.2) | n.s. |
| Duration of diarrhoea (days) | 6 (4–10) | 6 (4–9) | n.s. |
| Leucocytes (× 109/l) | 8.5 (6.1–12.1) | 8.7 (5.9–11.1) | n.s. |
| Antibiotic therapy (yes) | 13 (65.0) | 60 (60.6) | n.s. |
Data are median (IQR) or n (%). P values ≤0.05 are shown. Only p-values of significant results were shown. n.s. non-significant